AOD Thesaurus.  Annotated Hierarchy.  chemical substances by structure.  ZT - ZT12.2
b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search



ZTeheterocyclic compounds   d-out   qh
BT+ZDe organic compounds    qh   ah

ZT2heterocyclic acid   qh
NT+ZP18.4e nicotinic acid    qh   ah
 ZQ8.2e meperidine    qh   ah
+ZT6.10.4e indoleacetic acid    qh   ah
ZT2.2.  isonipecotic acid   qh
BT+ZT4.20e piperidine    qh   ah
ZT2.4.  nipecotic acid   qh

ZT41-ring heterocyclic compounds   qh
ZT4.2e.  azepine   qh
ZT4.2.2e.  .  pentylenetetrazole   qh
BT+YW8.6 convulsants    qh   ah
ZT4.4e.  azocine   qh
ZT4.4.2e.  .  cyclazocine   qh
ZT4.6e.  azole   qh
ZT4.6.2e.  .  tetrazole   qh
ZT4.6.2.2e.  .  .  tetrazolium salt   qh
ZT4.6.4e.  .  chlormethiazole   qh
ST clomethiazole
BT+YP4.6e alcohol withdrawal agents    qh   ah
ZT4.6.6e.  .  atipamezole   qh
BT+YP4.2e anti-alcohol-intoxication agents    qh   ah
ZT4.6.8e.  .  nitrefazole   qh
ST 2-methyl-4-nitro-1-(4-nitrophenyl) imidazole
BT+YP4.8.8e alcohol deterrents    qh   ah
ZT4.8e.  dioxin   qh
ZT4.8.2e.  .  tetrachlorodibenzodioxin   qh
ZT4.10.  fentanyl   qh
BT+BT6.4.10.2 schedule II opiates    qh   ah
+YW4.2e narcotic analgesics    qh   ah
+ZQ8 phenylpiperidine derivative opioids    qh   ah
+ZQ18e synthetic opioids    qh   ah
ZT4.12e.  furan   qh
ZT4.12.2e.  .  nitrofuran   qh
BT+YT12.2 urinary anti-infective agents    qh   ah
ZT4.12.2.2e.  .  .  furazolidone   qh
BT+YD8.2 ADH antagonists    qh   ah
ZT4.12.2.4e.  .  .  nitrofurantoin   qh
ZT4.12.4e.  .  ranitidine   qh
BT+YT10.8 antiulcer agents    qh   ah
+YT10.14 antisecretory agents    qh   ah
+YV6.4.4e histamine H2 receptor blockaders    qh   ah
ZT4.14e.  imidazoles   qh
ZT4.14.2e.  .  clonidine   qh
SN Originally developed as an antihypertensive medicine, clonidine has been found to be an effective nonopiate drug for controlling withdrawal from opiates and opioids. Subjects experience only mild discomfort detoxifying with clonidine, and its use has been proposed as a transition drug to bridge the gap in moving addicts from methadone treatment to antagonist (e.g., naltrexone) treatment.
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YP4.8.12.8 agents for alcohol-concurrent anxiety    qh   ah
+YP4.8.12.10 agents for alcohol-related cognitive impairment    qh   ah
+YP8 anti-nicotine-abuse agents    qh   ah
+YP12.4 opiate detoxification agents    qh   ah
+YP12.6 opiate withdrawal agents    qh   ah
+YT8.8 antihypertensive agents    qh   ah
ZT4.14.4e.  .  creatinine   qh
RT HF2e urinalysis    qh   ah
ZT4.14.6e.  .  hydantoin   qh
BT+YW4.6e anticonvulsants    qh   ah
ZT4.14.6.2e.  .  .  phenytoin   qh
BT+YP4.6.12 anti-alcohol-related-seizures agents    qh   ah
+YT8.2 antiarrhythmia agents    qh   ah
ZT4.14.6.4e.  .  .  thiohydantoin   qh
ZT4.14.6.4.2e.  .  .  .  phenylthiohydantoin   qh
ZT4.14.8e.  .  nitroimidazole   qh
ZT4.14.8.2e.  .  .  metronidazole   qh
BT+YD8.2 ADH antagonists    qh   ah
ZT4.14.10.  .  ondansetron   qh
BT+YP4.8.2.8 narcotic antagonist anti-alcohol-craving agents    qh   ah
+YV6.6.2e serotonin uptake inhibitors    qh   ah
ZT4.14.12e.  .  phentolamine   qh
BT+YD8.2 ADH antagonists    qh   ah
+YT8.8 antihypertensive agents    qh   ah
+YV12.2e alpha-adrenergic receptor blockaders    qh   ah
ZT4.14.14e.  .  tolazoline   qh
BT+YV12.2e alpha-adrenergic receptor blockaders    qh   ah
ZT4.16e.  oxazole   qh
ZT4.16.2.  .  isoxazoles   qh
HN Introduced 2000.
ZT4.16.2.2.  .  .  alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid   qh
HN Introduced 2000.
ST alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate
AMPA
ZT4.16.4e.  .  pemoline   qh
BT+BT6.8.4 schedule IV CNS stimulants    qh   ah
+YW8e CNS stimulants    qh   ah
ZT4.16.4.2e.  .  .  magnesium pemoline   qh
BT+YP10.8.10 agents for cocaine-concurrent mental disorders    qh   ah
+YP10.8.10.6 agents for cocaine-related cognitive impairment    qh   ah
+YW8e CNS stimulants    qh   ah
ZT4.16.6e.  .  trimethadione   qh
BT+YW4.6e anticonvulsants    qh   ah
ZT4.18e.  piperazine   qh
NT ZT8.16.2.2e flupenthixol    qh   ah
ZT4.18.2e.  .  amperozide   qh
HN Introduced 2000.
SN A derivative of piperazine with effects on stress-induced orders.
ZT4.18.4e.  .  trazodone   qh
BT+YP10.8.6 cocaine blockers    qh   ah
+YP10.8.10.2 agents for cocaine-concurrent depression    qh   ah
+YV6.6.2e serotonin uptake inhibitors    qh   ah
ZT4.20e.  piperidine   qh
NT BF6e phencyclidine    qh   ah
 ZT2.2 isonipecotic acid    qh   ah
ZT4.20.2e.  .  paroxetine   qh
HN Introduced 2000.
BT+YV6.6.2e serotonin uptake inhibitors    qh   ah
ZT4.20.4e.  .  penfluridol   qh
BT+YW4.10.2e antipsychotic tranquilizers    qh   ah
ZT4.20.6e.  .  perhexiline   qh
BT+YT8.14e calcium channel blockers    qh   ah
ZT4.20.8e.  .  piperidone   qh
NT ZJ2.10.10.6.2.2e thalidomide    qh   ah
ZT4.20.8.2e.  .  .  cycloheximide   qh
HN Introduced 1995.
BT+YQ4.14.6 antifungal antibiotics    qh   ah
ZT4.20.8.4e.  .  .  glutethimide   qh
SN A nonbarbiturate hypnotic used in the treatment of insomnia. Physical and psychological dependence on this drug have occurred.
ST Doriden
BT+BT6.4.4 schedule II CNS depressants    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
ZT4.22e.  pyran   qh
ZT4.22.2e.  .  patulin   qh
BT+YX2.12 mycotoxins    qh   ah
+YX4e carcinogens    qh   ah
ZT4.24e.  pyrazole   qh
ZT4.24.2e.  .  4-methylpyrazole   qh
ZT4.24.4e.  .  antipyrine   qh
BT+YQ2.2 nonsteroidal anti-inflammatory drugs    qh   ah
+YR2.2 nonnarcotic analgesics    qh   ah
ZT4.26e.  pyridine   qh
ZT4.26.2e.  .  aminopyrine   qh
NT BD2e nicotine    qh   ah
ZT4.26.2.2e.  .  .  pyrilamine   qh
BT+YV6.4.2e histamine H1 receptor blockaders    qh   ah
ZT4.26.2.4e.  .  .  tripelennamine   qh
SN An antihistamine that has recently come into use in combination with pentazocine as a substitute for heroin.
BT+YV6.4.2e histamine H1 receptor blockaders    qh   ah
ZT4.26.2.6e.  .  .  dihydropyridine   qh
NT ZP18.4.4e nimodipine    qh   ah
BT+YP4.6e alcohol withdrawal agents    qh   ah
ZT4.26.2.6.2e.  .  .  .  Bay K 8644   qh
HN Introduced 1995.
BT+YT8.12e calcium channel agonists    qh   ah
+ZP18.4e nicotinic acid    qh   ah
ZT4.26.2.6.4e.  .  .  .  isradipine   qh
HN Introduced 2000.
BT+YT8.8 antihypertensive agents    qh   ah
+YT8.14e calcium channel blockers    qh   ah
ZT4.26.2.6.6e.  .  .  .  nitrendipine   qh
HN Introduced 1995.
BT+YT8.8 antihypertensive agents    qh   ah
+YT8.14e calcium channel blockers    qh   ah
ZT4.26.2.8.  .  .  isonicotinic acid   qh
HN Introduced 1995.
NT ZF6.6e isoniazid    qh   ah
ZT4.26.2.10e.  .  .  nifedipine   qh
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YT8.14e calcium channel blockers    qh   ah
ZT4.26.4e.  .  pheniramine   qh
ZT4.26.4.2e.  .  .  brompheniramine   qh
ZT4.26.4.2.2e.  .  .  .  zimelidine   qh
ST zimeldine
BT+YP4.8.2.2e serotonergic anti-alcohol-craving agents    qh   ah
+YV6.6.2e serotonin uptake inhibitors    qh   ah
+YW6e antidepressants    qh   ah
ZT4.26.4.2.2.2e.  .  .  .  .  norzimelidine   qh
BT+YP4.8.2.2e serotonergic anti-alcohol-craving agents    qh   ah
ZT4.26.6e.  .  picoline   qh
ZT4.26.6.2e.  .  .  pyridoxal   qh
BT+YB12e vitamin B complex    qh   ah
RT YC16.14.6.14 pyridoxal kinase    qh   ah
ZT4.26.6.2.2e.  .  .  .  pyridoxal phosphate   qh
BT+YD4e coenzymes    qh   ah
ZT4.26.6.4e.  .  .  pyridoxamine   qh
BT+YB12e vitamin B complex    qh   ah
ZT4.26.8e.  .  picolinic acid   qh
ZT4.26.10e.  .  pyridinium compounds   qh
ZT4.26.10.2e.  .  .  paraquat   qh
BT+YX10.4.2 herbicides    qh   ah
ZT4.26.10.4e.  .  .  pyrithiamine   qh
BT+YT4 antimetabolites    qh   ah
ZT4.26.12e.  .  pyrithioxin   qh
ST pyritinol
BT+YP4.6e alcohol withdrawal agents    qh   ah
ZT4.28e.  pyrimidines   qh
ZT4.28.2e.  .  buspirone   qh
SN A nonbenzodiazepine anxiolytic. At present, it is regarded as having negligible dependence potential. See *+YW4.8 sedative-hypnotics* qh ah.
BT+YP4.8.2.2e serotonergic anti-alcohol-craving agents    qh   ah
+YP4.8.12.8 agents for alcohol-concurrent anxiety    qh   ah
+YW4.8e sedative-hypnotics    qh   ah
+YW4.8.6e antianxiety tranquilizers    qh   ah
ZT4.28.4e.  .  pyrimethamine   qh
BT+YQ4.10.4.2 antimalarials    qh   ah
ZT4.28.6e.  .  pyrimidinone   qh
ZT4.28.6.2e.  .  .  risperidone   qh
HN Introduced 2000.
SN A dopamine and serotonin antagonist; an antipsychotic agent.
BT+YV6.6e serotonin antagonists    qh   ah
+YW4.10.2e antipsychotic tranquilizers    qh   ah
ZT4.28.6.4e.  .  .  ritanserin   qh
HN ETOH descriptor 1995.
BT+YP4.8.2.10 neuropeptide anti-alcohol-craving agents    qh   ah
+YV6.6e serotonin antagonists    qh   ah
ZT4.28.6.6e.  .  .  barbiturates   qh
SN A group of central nervous system depressants that chemically are substituted derivatives of barbituric acid; examples are amobarbital, pentobarbital, and secobarbital. They are used as antiepileptics, anesthetics, hypnotics (sleep-inducing), and, less commonly, as anxiolytics or antianxiety drugs. Acute and chronic use induces effects similar to alcohol.
      Barbiturates have a narrow therapeutic-to-toxic dosage ratio and are often lethal in overdose.
      Barbiturates are associated with the full range of substance use disorders listed in ICD-10 (they are classed with F13).
NT+YW4.8.2e barbiturate sedative-hypnotics    qh   ah
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YR4e anesthetics    qh   ah
+YW4e CNS depressants    qh   ah
+YW4.4e general anesthetics    qh   ah
+YW4.6e anticonvulsants    qh   ah
RT+YW4.8e sedative-hypnotics    qh   ah
ZT4.28.6.6.4e.  .  .  .  amobarbital   qh
ST Amytal
BT+BT6.6.2 schedule III CNS depressants    qh   ah
+YW4.8.2.4 intermediate-acting barbiturates    qh   ah
ZT4.28.6.6.6e.  .  .  .  barbital   qh
ST Veronal
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YW4.8.2.2 long-acting barbiturates    qh   ah
ZT4.28.6.6.8e.  .  .  .  murexide   qh
ZT4.28.6.6.10e.  .  .  .  pentobarbital   qh
SN A short-acting, quick-onset barbiturate.
ST pentobarbital sodium
BT+BT6.4.4 schedule II CNS depressants    qh   ah
+BT6.6.2 schedule III CNS depressants    qh   ah
+YP6.6.2 barbiturate withdrawal agents    qh   ah
+YW4.8.2.6 short-acting barbiturates    qh   ah
ZT4.28.6.6.12e.  .  .  .  phenobarbital   qh
ST Luminal
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6e alcohol withdrawal agents    qh   ah
+YP4.6.12 anti-alcohol-related-seizures agents    qh   ah
+YP6.6.2 barbiturate withdrawal agents    qh   ah
+YW4.8.2.2 long-acting barbiturates    qh   ah
ZT4.28.6.6.14e.  .  .  .  primidone   qh
ZT4.28.6.6.16e.  .  .  .  secobarbital   qh
ST secobarbital sodium
Seconal
BT+BT6.6.2 schedule III CNS depressants    qh   ah
+YW4.8.2.6 short-acting barbiturates    qh   ah
ZT4.28.6.6.18e.  .  .  .  thiobarbiturates   qh
ZT4.28.6.6.18.4e.  .  .  .  .  thiopental   qh
ST Nembutal
Pentothal
thiopental sodium
BT+YW4.8.2.6 short-acting barbiturates    qh   ah
ZT4.28.6.8e.  .  .  uracil   qh
ZT4.28.6.8.2e.  .  .  .  thiouracil   qh
BT+YG34.6 thyroid antagonists    qh   ah
+YT4 antimetabolites    qh   ah
ZT4.28.6.8.2.2e.  .  .  .  .  propylthiouracil   qh
BT+YT4 antimetabolites    qh   ah
ZT4.30e.  pyrrole   qh
ZT4.30.2e.  .  porphyrins   qh
NT+GR16 porphyrin disorder    qh   ah
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.2.2e.  .  .  porphyrinogens   qh
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.2.4e.  .  .  protoporphyrins   qh
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.2.6e.  .  .  uroporphyrins   qh
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.4e.  .  bilirubin   qh
SN A tetrapyrrole bile pigment derived from the metabolism of porphyrins.
BT+YZ10 pigments and dyes    qh   ah
RT+GR18 hyperbilirubinemia    qh   ah
 HG12.8e liver function test    qh   ah
ZT4.30.4.2e.  .  .  biliverdin   qh
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.6e.  .  urobilin   qh
BT+YZ10 pigments and dyes    qh   ah
ZT4.30.8e.  .  urobilinogen   qh
BT+YZ10 pigments and dyes    qh   ah
RT HG12.8e liver function test    qh   ah
ZT4.30.10e.  .  porphobilinogen   qh
ZT4.30.12e.  .  tolmetin   qh
BT+YQ2.2 nonsteroidal anti-inflammatory drugs    qh   ah
+YR2.2 nonnarcotic analgesics    qh   ah
ZT4.32e.  pyrrolidine   qh
ZT4.32.2e.  .  dipyrrolidine   qh
ZT4.32.2.2e.  .  .  tremorine   qh
BT+YV10.4 ganglionic stimulants    qh   ah
ZT4.32.4e.  .  kainate   qh
HN Introduced 1995.
ST kainic acid
BT+YQ4.10 antiparasitic agents    qh   ah
ZT4.32.6e.  .  pyrrolidinone   qh
NT ZN2.20.2.2.2e piracetam    qh   ah
 ZN6.2e succinimide    qh   ah
ZT4.32.6.2e.  .  .  oxotremorine   qh
BT+YV10.4 ganglionic stimulants    qh   ah
ZT4.34e.  thiazine   qh
ZT4.34.2e.  .  piroxicam   qh
BT+YQ2.2 nonsteroidal anti-inflammatory drugs    qh   ah
+YR2.2 nonnarcotic analgesics    qh   ah
ZT4.36e.  thiazole   qh
ZT4.36.2e.  .  famotidine   qh
HN Introduced 1995.
BT+YT10.8 antiulcer agents    qh   ah
+YV6.4.4e histamine H2 receptor blockaders    qh   ah
ZT4.38e.  cimetidine   qh
BT+YT10.8 antiulcer agents    qh   ah
+YT10.14 antisecretory agents    qh   ah
+YV6.4.4e histamine H2 receptor blockaders    qh   ah

ZT62-ring heterocyclic compounds   qh
ZT6.2e.  cocaethylene   qh
HN Introduced 1995.
SN Cocaethylene is a psychoactive ethyl homologue of cocaine and is formed exclusively during the coadministration of cocaine and alcohol.
ST benzoylecgonine ethyl ester
BT+BP6 alcohol and cocaine    qh   ah
RT+EB10.12e ethanol metabolism    qh   ah
ZT6.4e.  benzazepines   qh
ZT6.4.2e.  .  benzodiazepines   qh
SN One of a group of structurally related drugs used mainly as antianxiety drugs, sedative/hypnotics, muscle relaxants, and antiepileptics. Also known as minor tranquilizers (deprecated) and anxiolytics.
      Benzodiazepines are frequently misused in conjunction with alcohol or opioid dependence. See *AA2.6 multiple drug use* qh ah.
NT+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
BT+YP4.8.12.8 agents for alcohol-concurrent anxiety    qh   ah
RT YK10e benzodiazepine receptors    qh   ah
+YW4e CNS depressants    qh   ah
+YW4.8.6.2 benzodiazepine tranquilizers    qh   ah
+ZJ2.6.10.2.2.2e GABA    qh   ah
ZT6.4.2.2e.  .  .  alprazolam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YP4.8.12.8 agents for alcohol-concurrent anxiety    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.4e.  .  .  RO 15-4513   qh
ST imidazobenzodiazepine
ZT6.4.2.6e.  .  .  carbamazepin   qh
BT+YP10.8.2 anti-cocaine-craving agents    qh   ah
ZT6.4.2.8e.  .  .  benzodiazepinones   qh
ZT6.4.2.8.2e.  .  .  .  anthramycin   qh
ZT6.4.2.8.4e.  .  .  .  bromazepam   qh
NT ZT6.4.2.8.30e temazepam    qh   ah
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
ZT6.4.2.8.6e.  .  .  .  camazepam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
ZT6.4.2.8.8e.  .  .  .  clonazepam   qh
ST Klonopin
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
ZT6.4.2.8.12e.  .  .  .  diazepam   qh
ST Valium
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YP6.6.4 benzodiazepine withdrawal agents    qh   ah
+YW4.8.6.2.4 long-acting benzodiazepines    qh   ah
ZT6.4.2.8.12.2e.  .  .  .  .  demethyldiazepam   qh
ZT6.4.2.8.14e.  .  .  .  flumazenil   qh
HN Changed descriptor 1995; through 1995 also use "flumazepil."
ST flumazepil
RO 15-1788
ZT6.4.2.8.16e.  .  .  .  flunitrazepam   qh
ST Rohypnol
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.8.18e.  .  .  .  flurazepam   qh
ST Dalmane
flurazepam hydrochloride
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.4 long-acting benzodiazepines    qh   ah
ZT6.4.2.8.20e.  .  .  .  lorazepam   qh
ST Ativan
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.8.22e.  .  .  .  nitrazepam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.8.24e.  .  .  .  oxazepam   qh
ST Serax
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.8.26e.  .  .  .  pirenzepine   qh
ZT6.4.2.8.28e.  .  .  .  prazepam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YT6.2 central muscle relaxants    qh   ah
+YW4.8.6.2.4 long-acting benzodiazepines    qh   ah
ZT6.4.2.8.30e.  .  .  .  temazepam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
+ZT6.4.2.8.4e bromazepam    qh   ah
ZT6.4.2.8.32e.  .  .  .  halazepam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.2.8.34e.  .  .  .  omeprazole   qh
BT+YT10.8 antiulcer agents    qh   ah
+YT10.14 antisecretory agents    qh   ah
ZT6.4.2.10e.  .  .  chlordiazepoxide   qh
SN An antianxiety tranquilizer derived from benzodiazepine.
ST chlordiazepoxide hydrochloride
Librium
methaminodiazepoxide
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.4 long-acting benzodiazepines    qh   ah
ZT6.4.2.10.2e.  .  .  .  clorazepate   qh
ST chlorazepate dipotassium
Tranxene
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6.8e benzodiazepines for alcohol withdrawal    qh   ah
+YW4.8.6.2.4 long-acting benzodiazepines    qh   ah
ZT6.4.2.12e.  .  .  midazolam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
ZT6.4.2.14e.  .  .  triazolam   qh
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
+YW4.8.6.2.2 short-acting benzodiazepines    qh   ah
ZT6.4.4e.  .  diltiazem   qh
ZT6.6e.  benzimidazoles   qh
ZT6.6.2e.  .  pimozide   qh
BT+YW4.10.2e antipsychotic tranquilizers    qh   ah
ZT6.8e.  benzopyrans   qh
ZT6.8.2e.  .  chroman   qh
NT BJ4.2e catechin    qh   ah
ZT6.8.2.2.  .  .  flavones   qh
BT+YB8e flavonoids    qh   ah
RT+YZ10 pigments and dyes    qh   ah
ZT6.8.2.2.2e.  .  .  .  isoflavonoids   qh
HN Introduced 2000.
ST isoflavones
ZT6.8.2.2.2.2e.  .  .  .  .  daidzin   qh
HN Introduced 2000.
SN Extracted from plant Pueraria lobata or kudzu root (radix puerariae).
ST daidzein
BT+YP4.2e anti-alcohol-intoxication agents    qh   ah
+YP4.8.2e anti-alcohol-craving agents    qh   ah
ZT6.8.2.2.2.4e.  .  .  .  .  puerarin   qh
HN Introduced 2000.
SN Extracted from plant Pueraria lobata or kudzu root (radix puerariae).
BT+YP4.2e anti-alcohol-intoxication agents    qh   ah
+YP4.8.2e anti-alcohol-craving agents    qh   ah
ZT6.8.4e.  .  coumarin   qh
HN ETOH descriptor 1995.
ZT6.8.4.2e.  .  .  4-hydroxycoumarin   qh
ZT6.8.4.2.2e.  .  .  .  warfarin   qh
BT+YX10.4.8 rodenticides    qh   ah
ZT6.10e.  indoles   qh
NT ZP10e ibogaine    qh   ah
ZT6.10.2e.  .  hydroxytryptophol   qh
HN Introduced 2000.
ZT6.10.2.2e.  .  .  5-hydroxytryptophol   qh
HN Introduced 2000.
ST 5-HTOL
BT+HB4.6.2.8.2 alcohol-related biochemical markers    qh   ah
ZT6.10.4e.  .  indoleacetic acid   qh
HN Introduced 1995.
BT+ZT2 heterocyclic acid    qh   ah
ZT6.10.4.2e.  .  .  hydroxyindoleacetic acid   qh
HN Introduced 1995.
ST 5-HIAA
5-hydroxyindoleacetic acid
HIAA
ZT6.10.6e.  .  indomethacin   qh
BT+YQ2.2 nonsteroidal anti-inflammatory drugs    qh   ah
+YR2.2.6 gout suppressants    qh   ah
ZT6.10.8e.  .  oxyphenisatin   qh
ZT6.10.10e.  .  melanin   qh
BT+YZ10 pigments and dyes    qh   ah
RT XH2.2.2e melanocyte    qh   ah
+ZN2.8.4e dopa    qh   ah
ZT6.10.12e.  .  tryptamine   qh
SN Nonhallucinogenic chemical from which the hallucinogenic drugs dimethyltryptamine (DMT), LSD, and psilocybin can be derived.
NT BF8.4 psilocybine    qh   ah
 YH2.2.2e melatonin    qh   ah
BT+ZN2.18.2.2e biogenic monoamines    qh   ah
ZT6.10.12.2e.  .  .  N,N-Dimethyltryptamine   qh
HN Introduced 2000.
SN An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.
ST 3-(2-(Dimethylamino)ethyl)indole
BT+YV6.6e serotonin antagonists    qh   ah
ZT6.10.12.4e.  .  .  serotonin   qh
ST 5-HT
5-hydroxytryptamine
hydroxytryptamine
BT+YJ2e neurotransmitters    qh   ah
+YJ2.4e monoamine neurotransmitters    qh   ah
+YM14 slow-reacting substances    qh   ah
+YV4 neuroregulators    qh   ah
+ZN2e amines    qh   ah
RT YK6.10.4e serotonin receptors    qh   ah
+YL6e antagonists    qh   ah
+YV6.6e serotonin antagonists    qh   ah
ZT6.12e.  isoquinolines   qh
NT ZP2e bicuculline    qh   ah
+ZP24e salsoline alkaloids    qh   ah
+ZQ12.2e papaverine    qh   ah
RT+ZG2.4e acetaldehyde    qh   ah
ZT6.12.2e.  .  emetine   qh
BT+YP4.8.10e conditioned alcohol aversion agents    qh   ah
RT+HK2.12.2e chemical aversion therapy    qh   ah
ZT6.12.6e.  .  nomifensine   qh
BT+YV4.2 dopaminergic agents    qh   ah
+YW6e antidepressants    qh   ah
ZT6.12.8e.  .  beta-carboline   qh
ZT6.14e.  penicillinic acid   qh
ZT6.16e.  pteridine   qh
ZT6.18e.  purines   qh
ZT6.18.2e.  .  purinone   qh
ZT6.18.2.2e.  .  .  xanthines   qh
NT+ZP28e xanthine alkaloids    qh   ah
BT+YW8e CNS stimulants    qh   ah
RT YC14.12.4e xanthine dehydrogenase    qh   ah
 YC14.12.6e xanthine oxidase    qh   ah
ZT6.18.4e.  .  flavins   qh
NT YB12.20e riboflavin    qh   ah
BT+YZ10 pigments and dyes    qh   ah
RT+YB8e flavonoids    qh   ah
ZT6.18.4.2e.  .  .  uric acid   qh
ZT6.20e.  quinazolines   qh
ZT6.20.2e.  .  ketanserin   qh
BT+YT14.6 platelet aggregation inhibitors    qh   ah
+YV6.6e serotonin antagonists    qh   ah
ZT6.20.4e.  .  methaqualone   qh
SN Nonbarbiturate sedative-hypnotic that produces sleep for about 6 to 8 hours, originally marketed as an alternative to barbiturates. When taken in large doses for purposes other than sleep inducement, it produces muscular relaxation, feelings of contentment, and total passivity, a state somewhat resembling drunkenness.
ST Quaalude
BT+BT6.2.4 schedule I CNS depressants    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
ZT6.20.6e.  .  prazosin   qh
BT+YT8.8 antihypertensive agents    qh   ah
+YV12.2e alpha-adrenergic receptor blockaders    qh   ah
ZT6.22e.  quinolines   qh
NT ZP4.2e quinidine    qh   ah
 ZP4.4e quinine    qh   ah
ZT6.22.2e.  .  quipazines   qh
ZT6.24e.  quinolones   qh
HN Introduced 2000.
ZT6.24.2e.  .  ciprofloxacin   qh
HN Introduced 2000.
BT+YQ4.6 antibacterial agents    qh   ah

ZT83-ring heterocyclic compounds   qh
ZT8.2e.  acridines   qh
ZT8.2.2e.  .  aminoacridine   qh
ZT8.2.2.2e.  .  .  quinacrine   qh
BT+YD8.2 ADH antagonists    qh   ah
+YQ4.10.4.2 antimalarials    qh   ah
+YQ6 antineoplastic agents    qh   ah
ZT8.2.2.4e.  .  .  imipramine   qh
ST imipramine hydrochloride
BT+YP4.8.12.6 agents for alcohol-concurrent depression    qh   ah
+YP4.8.12.8 agents for alcohol-concurrent anxiety    qh   ah
+YP10.8.6 cocaine blockers    qh   ah
+YP10.8.10.2 agents for cocaine-concurrent depression    qh   ah
+YW6.2 tricyclic antidepressants    qh   ah
ZT8.2.2.6e.  .  .  desipramine   qh
ST desmethylimipramine
BT+YP4.8.12.6 agents for alcohol-concurrent depression    qh   ah
+YP10.8.2 anti-cocaine-craving agents    qh   ah
+YP10.8.10.2 agents for cocaine-concurrent depression    qh   ah
+YP10.8.10.4 agents for cocaine-concurrent anxiety    qh   ah
+YW6.2 tricyclic antidepressants    qh   ah
ZT8.2.2.8e.  .  .  trimipramine   qh
ZT8.4e.  dibenzazepines   qh
ZT8.4.2e.  .  carbamazepine   qh
ST Depakene
Depakote
Tegretol
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YP4.6.12 anti-alcohol-related-seizures agents    qh   ah
+YP10.8 cocaine relapse prevention agents    qh   ah
ZT8.4.2.2e.  .  .  clozapine   qh
HN Introduced 2000.
BT+YV6.6e serotonin antagonists    qh   ah
+YW4.10.2e antipsychotic tranquilizers    qh   ah
ZT8.4.2.4e.  .  .  clomipramine   qh
HN Introduced 2000.
ZT8.6e.  dibenzoxazepines   qh
HN Introduced 2000.
ZT8.6.2e.  .  loxapine   qh
HN Introduced 2000.
ZT8.6.2.2e.  .  .  amoxapine   qh
HN Introduced 2000.
BT+YV6.6.2e serotonin uptake inhibitors    qh   ah
ZT8.8e.  dibenzoxepins   qh
ZT8.8.2e.  .  doxepin   qh
BT+YP4.8.12.6 agents for alcohol-concurrent depression    qh   ah
+YP10.8.10.2 agents for cocaine-concurrent depression    qh   ah
+YW4.8.6e antianxiety tranquilizers    qh   ah
ZT8.8.4e.  .  harmine   qh
BT+YW10e hallucinogens    qh   ah
+ZPe alkaloids    qh   ah
ZT8.10e.  phenanthroline   qh
ZT8.12e.  phenazine   qh
ZT8.12.2e.  .  thiothixene   qh
BT+YW4.10.2e antipsychotic tranquilizers    qh   ah
ZT8.14e.  phenothiazine   qh
ZT8.14.2e.  .  chlorpromazine   qh
HN Introduced 1995.
ST Thorazine
BT+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.14.4e.  .  perphenazine   qh
BT+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.14.6e.  .  prochlorperazine   qh
BT+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.14.8e.  .  promazine   qh
BT+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.14.10e.  .  promethazine   qh
ST promethazine hydrochloride
BT+YV6.2 antiemetics    qh   ah
+YV6.4.2e histamine H1 receptor blockaders    qh   ah
+ZN2.4e propylamine    qh   ah
ZT8.14.12e.  .  thioridazine   qh
BT+YP4.8.12.2 dopaminergic blockers for alcohol-concurrent mental disorders    qh   ah
+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.14.14e.  .  trifluoperazine   qh
BT+YW4.10.2.4 phenothiazine tranquilizers    qh   ah
ZT8.16e.  xanthene   qh
ZT8.16.2e.  .  thioxanthene   qh
ZT8.16.2.2e.  .  .  flupenthixol   qh
BT+YP10.8 cocaine relapse prevention agents    qh   ah
+YP10.8.2 anti-cocaine-craving agents    qh   ah
+YW4.10.2e antipsychotic tranquilizers    qh   ah
+ZT4.18e piperazine    qh   ah

ZT104 or more ring heterocyclic compounds   qh
ST 4-ring or more heterocyclic compounds
NT+ZQ4 phenanthrene derivative opioids    qh   ah
RT+ZP8 ergot alkaloids    qh   ah
ZT10.2e.  yohimban   qh
NT ZP26.2e reserpine    qh   ah
 ZP26.4e yohimbine    qh   ah
RT+ZP26e rauwolfia alkaloids    qh   ah

ZT12bridged-ring heterocyclic compounds   qh
NT ZQ4.6.4e naloxone    qh   ah
 ZQ4.6.6e naltrexone    qh   ah
ZT12.2e.  quinuclidine   qh
NT ZJ2.10.4.4.2e quinuclidinyl benzilate    qh   ah


b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search

classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept